Closed |
S1826 |
Phase III Study of AVD plus nivolumab or BV in pts >/= 12 years in newly diagnosed, advanced cHL |
7/19/2019 |
12/1/2022 |
100% |
|
|
Closed |
S1929 |
Phase II Study of Maintenance Atezolizumab Versus Atezolizumab in Combination with Talazoparib in Patients with SLFN11 Positive Extensive Stage Small Cell Lung Cancer (SCLC) |
6/15/2020 |
12/15/2022 |
100% |
|
|
Closed |
S1934 |
NASSIST |
9/9/2021 |
3/1/2023 |
0% |
|
|
Closed |
S1800D |
LUNGMAP S1800D: Non-match Sub-Study |
2/15/2022 |
3/10/2023 |
17% |
|
|
Closed |
S1900F |
A Randomized Phase II Study of Carboplatin and Pemetrexed With Or Without Selpercatinib In Patients With Non-Squamous RET Positive Stage IV NSCLC and Progression of Disease On Prior RET Directed Therapy |
7/25/2022 |
6/27/2023 |
0% |
|
|
Closed |
S1600 |
Effect of Immune-Enhancing Nutrition on Radical Cystectomy Outcomes |
2/21/2019 |
10/20/2023 |
100% |
|
|
Closed |
S2011 |
SWOG GAPTrial |
10/6/2021 |
11/15/2023 |
3% |
|
|